J Korean Pain Soc.  1995 Apr;8(1):37-42.

Effects of Morphine and Morphine-Ketorolac Tromethamine Intravenous Infusion for Postoperative Pain

Affiliations
  • 1Department of Anesthesiology, Wonkwang University Medical School, Iri, Korea.

Abstract

The intermittent injection of analgesics is a inadquate method for postoperative pain control. Recently a non-electronic, disposable and portable infusor (Boxter Two Day InfusorR) has been developed which can deliver analgesics with 2 ml/h speed continuousely. The present study examined the effects of three methods of pain management on recovery in 306 patients undergoing elective surgery in Wonkwang University Hospital. Group 1 (n=106) received i.m. Valentac[R] on a PRN basis. Group 2 (n= 100), initial 2 mg of bolus morphine was fol lowed by 48 mg of continuous infusion. Group 3 (n=100), initial 2 mg of morphine followed by morphine 18 mg-ketorolac 120 mg. We evaluated an analgesic efficacy with NRS (numerical rating scale) at 12, 24, 36, 48, 60 and 72 hours after the operation. The side effects (nausea, vomiting, pruritus, sedation and respiratory depression) were evaluated. In group 1, we asked major concern before operation and efficacy of pain control with pain severity (no pain, mild pain, moderate pain, severe pain). The results were as follows: 1) Major concern before operation is pain (40%). 2) 53% of patients suffered pain in group l. 3) Morphine and morphine-ketorolac infusion groups were superior to the i.m. (ValentacR) group with respect to postoperative analgesia. 4) In group 3 (morphine-ketorolac), there was no pruritus and mild nausea and vomiting.

Keyword

Morphine; Ketorolac; Postoperative pain

MeSH Terms

Analgesia
Analgesics
Humans
Infusion Pumps
Infusions, Intravenous*
Ketorolac
Morphine*
Nausea
Pain Management
Pain, Postoperative*
Pruritus
Tromethamine*
Vomiting
Analgesics
Ketorolac
Morphine
Tromethamine
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr